Alemtuzumab
Products in Health Canada’s databases that list Alemtuzumab as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 3
- 2 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 22
- Products in all
- 3
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| LEMTRADA (12 MG) | 02418320 | Marketed | Sanofi-Aventis Canada Inc. | |
| MABCAMPATH (30 MG) | 02290960 | Marketed | Sanofi-Aventis Canada Inc. | |
| MABCAMPATH (10 MG) | 02273993 | Cancelled Post Market | Genzyme Corporation |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- LEMTRADAAugust 18, 2026 · NOC 38135
- MABCAMPATHAugust 28, 2024 · NOC 33893
- LEMTRADAAugust 8, 2024 · NOC 33778
- MABCAMPATHApril 19, 2024 · NOC 33109
- LEMTRADAApril 19, 2024 · NOC 33110
- MABCAMPATHMay 25, 2023 · NOC 30852
- LEMTRADAMay 4, 2023 · NOC 30630
- LEMTRADAJune 10, 2022 · NOC 28388
- LEMTRADAJanuary 19, 2022 · NOC 27427
- LEMTRADAOctober 8, 2021 · NOC 26824
- LEMTRADAApril 29, 2021 · NOC 25756
- LEMTRADAFebruary 16, 2021 · NOC 25228
- MABCAMPATHOctober 5, 2020 · NOC 24426
- LEMTRADAMay 15, 2020 · NOC 23648
- MABCAMPATHMay 15, 2020 · NOC 23655
- LEMTRADASeptember 3, 2019 · NOC 22596
- MABCAMPATHApril 26, 2019 · NOC 22098
- LEMTRADADecember 12, 2013 · NOC 15031
- MABCAMPATHJuly 27, 2009 · NOC 10445
- MABCAMPATHJanuary 27, 2009 · NOC 10011
- MABCAMPATHJanuary 19, 2007 · NOC 8532
- MABCAMPATHNovember 30, 2005 · NOC 7640